Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX

ConditionsSubstance Use HIV Prevention Sexually Transmitted Infections (STIs)

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorInstitute of HIV Research and Innovation Foundation, Thailand

About this trial

The study is a pre-implementation cross-sectional study exploring chemsex behaviors among transgender persons and gathering perspectives from multiple stakeholders to inform the development of transgender-tailored harm reduction services.

Eligibility criteria

Qualifiers

Age ≥18 years

Able to communicate in Thai

Provide informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

Understanding of chemsex patterns, impacts, and service needs among transgender persons

Treatment groups

50 Participants

are divided into 3 treatment groups

Locations

Tangerine Clinic, Institute of HIV Research and Innovation10330, Pathum WanBangkok, Thailand

Sponsors and collaborators

Institute of HIV Research and Innovation Foundation, Thailand

Lead sponsor

amfAR, The Foundation for AIDS Research

Collaborator

Source ClinicalTrials.gov